Signaling Pathways - Bladder Carcinoma - Non-small Cell Lung Carcinoma - Bladder Cancer
清除全部
- B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂,蒽环类抗生素
- B1858 Tranexamic Acid中文名: 氨甲环酸Target: fibrinolysisSummary: 纤溶酶原激活的竞争性抑制剂
- B1474 FT-207 (NSC 148958)中文名: 替加氟Summary: DNA/RNA合成抑制剂
- B1321 OTSSP167Target: MELKSummary: MELK抑制剂
- B2186 GSK2636771Target: PI3KSummary: PIK3抑制剂
- A8549 LY335979 (Zosuquidar 3HCL)1 Citation中文名: 唑喹达三盐酸盐Target: P-glycoprotein (P-gp)Summary: Pgb(P糖蛋白)抑制剂
- A8477 MK-8776 (SCH-900776)Target: ChkSummary: Chk1高效选择性抑制剂
- A2168 Dovitinib (TKI-258, CHIR-258)2 Citation中文名: 多韦替尼Target: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 多靶点RTK抑制剂
- A8219 Gefitinib (ZD1839)3 Citation中文名: 吉非替尼Target: EGFRSummary: EGFR抑制剂
- A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR调节剂